Prelude Capital Management’s Amsurg Corp AMSG Stock Holding History

Prelude Capital Management’s Portfolio AMSG Stock Details AMSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-200	Closed	-$15K	–	1737
2015 Q4	$15K	Buy	+200	New	+$15.8K	﹤0.01%	1230
2015 Q3	–	Sell	-375	Closed	-$26K	–	2007
2015 Q2	$26K	Sell	375 -375	-50%	-$25.1K	﹤0.01%	1310
2015 Q1	$46K	Sell	750 -1,550	-67%	-$89.5K	0.01%	1336
2014 Q4	$126K	Sell	2,300 -3,400	-60%	-$173K	0.02%	916
2014 Q3	$285K	Buy	5,700 +400	+8%	+$20K	0.04%	576
2014 Q2	$242K	Buy	5,300 +4,550	+607%	+$209K	0.03%	669
2014 Q1	$35K	Sell	750 -2,300	-75%	-$101K	﹤0.01%	1501
2013 Q4	$140K	Buy	3,050 +2,300	+307%	+$102K	0.02%	732
2013 Q3	$30K	Buy	+750	New	+$29.1K	﹤0.01%	1151

Other funds holding AMSG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prelude Capital Management's AMSG Position: Q1 2016 in Review

Prelude Capital Management sold out of Amsurg Corp (AMSG) in Q1 2016, closing a stake of 200 shares — an estimated $15K sold.

Prelude Capital Management first reported a position in AMSG in Q3 2013 and held it in 9 quarters. The position peaked at $285K in Q3 2014. 303 funds tracked by Wall St. Rank hold AMSG as of Q1 2016.

Prelude Capital Management reported no remaining Amsurg Corp position as of Q1 2016 after selling out during the quarter.
Prelude Capital Management sold 200 Amsurg Corp shares in Q1 2016, an estimated $15K.
Prelude Capital Management first reported a position in Amsurg Corp in Q3 2013 and held it in 9 quarters.
Prelude Capital Management's Amsurg Corp position peaked at $285K in Q3 2014.
303 funds tracked by Wall St. Rank held Amsurg Corp as of Q1 2016.

Based on Prelude Capital Management's 13F filing for Q1 2016, filed 16 May 2016.